Find an expert

Lisa Akison is a Senior Lecturer in the School of Biomedical Sciences (SBMS) at the University of Queensland. She has conducted research using rodent models for over 30 years and has been a reproductive biologist since 2005. She completed her PhD (2013) and early Post-doctoral training at the Robinson Institute, University of Adelaide, where she examined the molecular regulation of ovulation and oviductal function. Following her move to UQ in 2015, her research focussed on the developmental origins of health and disease, where she examined developmental programming of various organs and physiological processes. In particular, she has examined the impact of prenatal alcohol exposure, examining impacts on the embryo, fetus and adult offspring. She is also interested in the role that the placenta plays in mediating these effects.

Lisa received training in systematic review and meta-analysis methodology in 2016 and has since published systematic reviews on diverse topics in child and infant health. She now teaches critical appraisal of clinical studies and systematic review methodology to 3rd year biomedical science students, as well as endocrinology, physiology and histology. She has research interests in the Scholarship of Teaching and Learning, and is a current member of the Biomedical Education Research Group at SBMS.

Professor Kristen Gibbons is Group Lead of the Children’s Intensive Care Research Program at the Child Health Research Centre, The University of Queensland, Co-Chair of the Australian and New Zealand Intensive Care Society Paediatric Study Group (ANZICS PSG).

Professor Gibbons holds qualifications in mathematics, information technology, biostatistics, and research communication, and completed her PhD in Biostatistics at UQ. Her career has been dedicated to transforming outcomes for critically ill children through the design and delivery of large-scale international clinical trials and the development of innovative digital platforms to support high-quality research.

She has been instrumental in leading landmark studies, including the NITRIC trial, the largest trial ever undertaken in paediatric congenital heart disease surgery. This trial demonstrated no benefit of using nitric oxide during cardiopulmonary bypass, changing clinical practice internationally and influencing guidance from the American Academy of Paediatrics. Alongside this, Professor Gibbons has pioneered a comprehensive clinical trials digital platform now used across more than 20 projects and 10,000 patient records worldwide.

Professor Gibbons’ research spans clinical trial methodologies, epidemiology, machine learning, prediction modelling, and bioethics, with a strong commitment to improving consent practices in paediatric and adult intensive care research. Her leadership has attracted over $22 million in competitive grant funding, including major NHMRC and MRFF awards, and her contributions have been recognised with the UQ Faculty of Medicine Leader of the Future Award (2023) and the Child Health Research Centre Collaborator of the Year Award (2024).

She is also deeply invested in training and mentoring the next generation of clinician-researchers and data scientists, supervising PhD, Masters, and biostatistics students.

Associate Professor Emma Hamilton-Williams’ career focuses on understanding how immune tolerance is disrupted leading to the development of the autoimmune disease type 1 diabetes. She received her PhD from the Australian National University in 2001, followed by postdoctoral training in Germany and the Scripps Research Institute in the USA.

In 2012, she started a laboratory at the Frazer Institute, University of Queensland where she investigates the gut microbiota as a potential trigger or therapy target for type 1 diabetes, as well as developing an immunotherapy for type 1 diabetes. The overall aim of her research is to find new ways to prevent or treat the underlying immune dysfunction causing autoimmunity.

She is Chief Scientific Officer for an Australia-wide pregnancy-birth cohort study of children at increased risk of type 1 diabetes, which aims to uncover the environmental drivers of this disease. Her laboratory uses big-data approaches including proteomics, metabolomics and metagenomics to understand the function of the gut microbiota linked to disease.

She recently conducted a clinical trial of a microbiome-targeting biotherapy aimed at restoring a healthy microbiome and immune tolerance, with an ultimate aim of preventing type 1 diabetes.

Dr Katelyn Melvin is Lecturer in Speech Pathology in the School of Health and Rehabilitation Sciences, Faculty of Health, Medical and Behavioural Sciences at The University of Queensland. Katelyn is committed to collaborating with families and communities to drive meaningful, long-term improvements in developmental outcomes for children. She is passionate about fostering innovation in teaching and learning in higher education, with a particular focus on simulation-based education to advance professional development. Her mixed-methods research explores family-centred practice, health promotion and prevention, and collaborative approaches that drive health service innovation and improve service delivery in the early years.

Dr Felipe Retamal-Walter is a bilingual speech pathologist, audiologist, and early career academic at The University of Queensland. His research focuses on improving access, equity, and quality in communication and hearing healthcare across the lifespan. Drawing on over 15 years of experience across Chile and Australia, Felipe leads and contributes to international research projects funded nationally and internationally. He is a recipient of multiple academic recognitions, including top-cited article awards, international fellowships, and an invention patent for neonatal care technology.

Felipe uses mixed methods, implementation science, and participatory research approaches to co-design and evaluate practical, person-centred models of care. He works in partnership with families, students, clinicians, educators, and policymakers across many regions in Australia and the Pacific, North and South America, and Europe to develop tools, training, and systems that respond to the needs of underserved and diverse communities.

Felipe’s research themes include:

• Design, improvement, and evaluation of service delivery models to enhance access to timely and high-quality services. This is achieved by building honest, transparent, and long-lasting partnerships that consider all stakeholders as equal partners in care: clients, families, communities, healthcare professionals, and policymakers.
• Development and validation of implementation tools and measures to enhance person- and family-centred care, engagement, and shared decision-making in healthcare services. These tools promote equitable, community-based access for people across the lifespan in diverse regions and contexts.
• Implementation of culturally responsive education and training approaches to prepare health professions students for inclusive, digitally enabled, and person-centred practice in global and diverse contexts.

Felipe is an active member of the World Health Organization’s World Hearing Forum. He serves on The University of Queensland’s Cultural Inclusion Council and several research engagement themes. His work has informed national policy, clinical training programs, and service delivery innovations across Australia and other global settings. As an advocate for inclusion, Felipe also leads interdisciplinary initiatives that embed equity, diversity, and cultural responsiveness in healthcare and health education systems.

My group works to understand and improve sleep for children and families. Sleep is a key ‘pillar of health’ alongside nutrition and activity. It is critical for healthy development, growth, learning, social and emotional functioning, and community participation.

I am the UQ Node Director for the ARC Centre of Excellence for Children and Families over the Life Course (the Life Course Centre). The Life Course Centre is committed to understanding and overcoming the problems of disadvantage, and to helping improve the lives of disadvantaged children and families. The Centre brings together researchers across multiple disciplines in four leading Universities, and significant government and non-government agencies to address these questions.

I am also the UQ Node director for the ARC centre of Excellence for the Digital Child. The Digital Child aims to support children growing up in the rapidly changing digital world, and provide strong evidence and guidance for children, families, educators, government and other concerned with children’s wellbeing.

We collaborate with many other groups around broader issues of sleep and technology, sleep and the environment (including disasters), mental health and wellbeing, pain, disability, and new technologies and approaches. Our work has been supported by the ARC, NHMRC, the MRFF, the NIH, and the DSTG. We use a wide range of methods and measures, including direct physiological and behavioural measurement (inc. ECG, EEG, EMG, actigraphy, computerized tests, simulations, environmental monitoring etc.), quantitative methods (inc. experimental and secondary data approaches), and qualitative methods including co-design and co-conduct approaches.

My team has additional expertise in evaluation of health and other services for government and other agencies, the design of complex interventions, and community consultation and engagement.

https://lifecoursecentre.org.au

https://digitalchild.org.au

Dr. Ayaho Yamamoto is the Group Leader of Laboratory Science at the Children's Health and Environmental Program and is a research fellow in the field of Biomedical Science. Her research focuses on understanding the mechanistic links between environmental exposures and adverse respiratory outcomes. In particular, she focuses on the cellular responses following air pollution exposure and/or viral infection on human respiratory epithelium, and the age differences in immune defence mechanisms. Investigate on early intervention strategies with dietary antioxidants to improve respiratory health and reduce the risk of long-term chronic diseases.

Dr. Yamamoto has a Bachelor of Science in Environmental Health and Public Health; her research focused on childhood asthma. She has a Master of Science in Biomedical Science and Pharmacology; the research focus was to understand the mechanisms and to test new drugs for osteoporosis and chondrosarcomas metastasis. She has worked in a Uni-based start-up company for drug development.